These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 19630832)

  • 21. Endothelium-derived contracting factors in resistance arteries of young spontaneously hypertensive rats before development of overt hypertension.
    Jameson M; Dai FX; Lüscher T; Skopec J; Diederich A; Diederich D
    Hypertension; 1993 Mar; 21(3):280-8. PubMed ID: 8386699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective Effects of Glucagon-like Peptide 1 on Endothelial Function in Hypertension.
    Liu L; Liu J; Huang Y
    J Cardiovasc Pharmacol; 2015 May; 65(5):399-405. PubMed ID: 25384196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes.
    Matsumoto T; Nakayama N; Ishida K; Kobayashi T; Kamata K
    J Pharmacol Exp Ther; 2009 Apr; 329(1):324-34. PubMed ID: 19164460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary endothelial dysfunction: hypertension and heart failure.
    Boulanger CM
    J Mol Cell Cardiol; 1999 Jan; 31(1):39-49. PubMed ID: 10072714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical review of the role of endothelial factors in the pathogenesis of hypertension.
    Schiffrin EL
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S3-6. PubMed ID: 11811373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive drugs and reversing of endothelial dysfunction in hypertension.
    Taddei S; Virdis A; Ghiadoni L; Sudano I; Salvetti A
    Curr Hypertens Rep; 2000 Feb; 2(1):64-70. PubMed ID: 10981130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of antihypertensive drugs on endothelial dysfunction: clinical implications.
    Taddei S; Virdis A; Ghiadoni L; Sudano I; Salvetti A
    Drugs; 2002; 62(2):265-84. PubMed ID: 11817973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The endothelium of resistance arteries: physiology and role in hypertension.
    Schiffrin EL
    Prostaglandins Leukot Essent Fatty Acids; 1996 Jan; 54(1):17-25. PubMed ID: 8992488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelium-mediated control of vascular tone: COX-1 and COX-2 products.
    Félétou M; Huang Y; Vanhoutte PM
    Br J Pharmacol; 2011 Oct; 164(3):894-912. PubMed ID: 21323907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial dysfunction in hypertension.
    Vanhoutte PM
    J Hypertens Suppl; 1996 Dec; 14(5):S83-93. PubMed ID: 9120689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events.
    Enseleit F; Hürlimann D; Lüscher TF
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S21-30. PubMed ID: 11392475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelium, aging, and hypertension.
    Taddei S; Virdis A; Ghiadoni L; Versari D; Salvetti A
    Curr Hypertens Rep; 2006 Apr; 8(1):84-9. PubMed ID: 16600164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of endothelium in human hypertension.
    Taddei S; Virdis A; Ghiadoni L; Salvetti A
    Curr Opin Nephrol Hypertens; 1998 Mar; 7(2):203-9. PubMed ID: 9529624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial dysfunction in the pulmonary vascular bed.
    Chen YF; Oparil S
    Am J Med Sci; 2000 Oct; 320(4):223-32. PubMed ID: 11061346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of Type 2 diabetes.
    Matsumoto T; Kakami M; Noguchi E; Kobayashi T; Kamata K
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1480-90. PubMed ID: 17513496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial function in hypertension.
    Mattei P; Virdis A; Ghiadoni L; Taddei S; Salvetti A
    J Nephrol; 1997; 10(4):192-7. PubMed ID: 9377726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cilazapril and indomethacin on endothelial dysfunction in the aortas of spontaneously hypertensive rats.
    Rubanyi GM; Kauser K; Gräser T
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S23-30. PubMed ID: 7508048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis.
    Barton M
    Pflugers Arch; 2010 Oct; 460(5):825-37. PubMed ID: 20635093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelium-dependent relaxation mechanisms involve nitric oxide and prostanoids in the isolated bovine digital vein.
    Comerma-Steffensen S; Risso A; Ascanio-Evanoff E; Zerpa H
    J Vet Pharmacol Ther; 2019 May; 42(3):361-367. PubMed ID: 30888081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension.
    Widlansky ME; Price DT; Gokce N; Eberhardt RT; Duffy SJ; Holbrook M; Maxwell C; Palmisano J; Keaney JF; Morrow JD; Vita JA
    Hypertension; 2003 Sep; 42(3):310-5. PubMed ID: 12874094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.